[1] 潘卫利,方红,郑敏,等.伊曲康唑治疗甲真菌病多中心临床疗效观察[J].临床皮肤杂志,2004,33(8):504-505.
[2] 丁国华.伊曲康唑的不良反应[J].中国航天工业医学,2000,2(4):75-76.
[3] 吴终慧,雷招宝.伊曲康唑的不良反应[J].药物不良反应杂志,2004,3:166-167.
[4] 顾伟成.现代皮肤病性病治疗学:甲癣[M].北京医科大学中国协和医科大学联合出版社,1999:176-178.
[5] 罗以德.斯皮仁诺短程加间歇疗法治疗甲真菌病的临床研究[J].实用预防医学,2003,10(2):202-203.
[6] Boger RH. Drug interactions of the statins and consequences for drug selection[J].Int J Clin Pharmacol Ther,2001,39(9):369-382.
[7] Schneider B,Gerdsen R,Plat J,et al. Effects of high-dose itraconazole treatment on lipoproteins in men[J].Int J Clin Pharmacol Ther,2007,45(7):377-384.
[8] Vlahakos DV, Manginas A, Chilidou D, et al.Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine[J].Transplantation,2002,73(12):1962-1964.
[9] 苗彩云,陈漪,陈江飞. 伊曲康唑影响的药代动力学相互作用研究进展[J]. 中国临床药理学与治疗学,2009,14(10):1183-1192.
[10] NeuVonen PJ, Jalava KM. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid[J].Clin Pharmacol Ther,1996,60(1):54-61. |
